Overview of Dr. Fine
Dr. Howard Fine is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and New York-Presbyterian Hospital. He received his medical degree from Icahn School of Medicine at Mount Sinai and has been in practice 36 years. He is one of 378 doctors at New York-Presbyterian Hospital and one of 378 doctors at New York-Presbyterian Hospital who specialize in Oncology. He has more than 100 publications and over 500 citings.
Office
1305 York Avenue
10th Floor
New York, NY 10021
Education & Training
Icahn School of Medicine at Mount SinaiClass of 1984
Certifications & Licensure
FL State Medical License 2022 - Present
NY State Medical License 2012 - 2026
MD State Medical License 2000 - 2014
PA State Medical License 1986 - 1988- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging Start of enrollment: 2016 Aug 01
- A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme Start of enrollment: 2021 May 18
- Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma Start of enrollment: 2022 Feb 14
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 38 citationsReport of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD)Patrick Y. Wen, Timothy F. Cloughesy, Benjamin M. Ellingson, David A. Reardon, Howard A. Fine
Neuro-Oncology. 2014-10-01 - 110 citationsPhase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).Patrick Y. Wen, W. K. Alfred Yung, Kathleen R. Lamborn, Andrew D. Norden, Timothy F. Cloughesy
Neuro-Oncology. 2009-12-01 - 268 citationsModeling Patient-Derived Glioblastoma with Cerebral Organoids.Amanda G. Linkous, Demosthenes Balamatsias, Matija Snuderl, Lincoln A. Edwards, Ken Miyaguchi
Cell Reports. 2019-03-19
Press Mentions
Kazia Enters Clinical Collaboration with Cornell University for Phase II Clinical Study Using Paxalisib in Combination with Ketogenic Diet for GlioblastomaJune 15th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
